AgeX Therapeutics, Inc. announced that, on September 1, 2023, Dr. Michael H. May informed that he does not intend to stand for re-election as a director at Company's next annual meeting of stockholders, which is expected to be held during December of this year. Dr. May is President and Chief Executive Officer of CCRM (Centre for Commercialization of Regenerative Medicine) and of CCRM Enterprises Inc., the investment arm of CCRM. Dr. May informed AgeX that his decision was due to his need to reduce commitments to external activities, and that his decision was not because of a disagreement with AgeX on any matter relating to AgeX?s operations, policies, or practices.